Cancer News and Research

Latest Cancer News and Research

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

As part of John Muir Health’s Minimally Invasive Thoracic Surgery program, a minimally invasive thymectomy – removal of the thymus gland – was successfully performed recently at the John Muir Medical Center – Concord Campus. This procedure, designed to minimize trauma to patients, uses the latest generation da Vinci® Si Surgical System to help surgeons see vital anatomical structures more clearly and to perform a more precise operation.

24 Feb 2010

Researchers to test Radio-embolisation technique in patients with bowel cancer

Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.

24 Feb 2010

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon’s PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

24 Feb 2010

Novelos Therapeutics' NOV-002 Phase 3 NSCLC trial fails to meet primary survival endpoint

Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the primary endpoint of improvement in overall survival was not met in Novelos’ pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy. Detailed trial results are expected to be presented via appropriate scientific venue later this year.

24 Feb 2010

Researchers team up to monitor and assess potential infectious disease threats to Vancouver

As the world watches the Vancouver Olympics, researchers at St. Michael's Hospital in Toronto and Children's Hospital Boston have teamed up to monitor and assess potential infectious disease threats to Vancouver during the Winter Games by integrating two independently developed intelligence systems that focus on global infectious diseases; bio.DIASPORA and HealthMap.

24 Feb 2010

Synovis Life Technologies reports net revenue of $15.2M for first-quarter fiscal 2010

Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.

24 Feb 2010

Lack of knowledge and awareness impeding efforts to control HBV and HCV

A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern. The major factor impeding efforts to control HBV and HCV is lack of knowledge and awareness among health care providers, social service professionals, members of the public, and policy-makers.

24 Feb 2010

Frozen/thawed ovarian tissue transplant: Woman has two children from separate pregnancies

For the first time, a woman has given birth to two children after her fertility was restored using transplants of ovarian tissue that had been removed and frozen during her cancer treatment and then restored once she was cured.

24 Feb 2010

Over-produced PKC-iota oncogene linked to poor pancreatic cancer patient survival

Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKC), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKC in laboratory animals led to a significant decrease in pancreatic tumor growth and spread.

24 Feb 2010

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has launched an expanded test panel to detect 17 B-RAF mutations for research use to enhance the understanding of B-RAF mutations.

24 Feb 2010

Phase III trial results of Osiris Therapeutics' Prochymal for GvHD to be presented at BMT Tandem Meeting

Osiris Therapeutics, Inc. today announced that results from the Phase III trial evaluating Prochymal for the treatment of steroid-refractory acute graft vs. host disease (GvHD) will be presented by Paul Martin, M.D., of the Fred Hutchinson Cancer Research Center and Paul Szabolcs, M.D., of Duke University Medical Center at the 2010 BMT Tandem Meeting. The meeting is being held February 24-28 in Orlando, Florida.

24 Feb 2010

Guardian offers six questions to help employees and their families avoid critical illness

If you want to protect your finances from the costs of heart disease, and keep your heart healthy, the experts at The Guardian Life Insurance Company of America, a leading provider of employee benefits, have compiled important questions that you should ask yourself before American Heart Month ends.

24 Feb 2010

ES cells-functions: Condensins promote mitotic progression and maintain interphase chromatin compaction

Regulatory proteins common to all eukaryotic cells can have additional, unique functions in embryonic stem (ES) cells, according to a study in the February 22 issue of the Journal of Cell Biology (www.jcb.org). If cancer progenitor cells-which function similarly to stem cells-are shown to rely on these regulatory proteins in the same way, it may be possible to target them therapeutically without harming healthy neighboring cells.

24 Feb 2010

Idera Pharmaceuticals presents IMO-3100 TLR antagonist mechanism of action data at Keystone conference

Idera Pharmaceuticals, Inc. today presented data on the mechanism of action of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9, in a preclinical primate model at the Keystone Symposia conference “Tolerance and Autoimmunity” being held February 21-26 in Taos, New Mexico. Idera is developing IMO-3100 for the treatment of autoimmune diseases. The presentation entitled “IMO-3100, a novel antagonist, suppresses TLR7- and TLR9-mediated immune responses in non-human primates” was made by Idera scientists.

24 Feb 2010

Religious belief can reduce depression symptoms

Research suggests that religious belief can help protect against symptoms of depression, but a study at Rush University Medical Center goes one step further.

24 Feb 2010

USPSTF-recommended guidelines lead to decline in mammograms and early detection programs for women under 50

In some states women ages 40 to 49 have less access to mammograms since the U.S. Preventive Services Task Force (USPSTF) released its recommendations to change breast cancer screening guidelines last November, according to a recent survey conducted by the Avon Foundation for Women. The USPSTF recommended changing the current mammography screening guidelines for average risk women to begin biennial screening at age 50 instead of annual mammograms starting at age 40.

24 Feb 2010

Arsenic exposure may increase cancer risk, says study

Researchers have found a new oncogenic signaling pathway by which the environmental toxin arsenic may lead to adverse health effects, including bladder cancer. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.

24 Feb 2010

ACS re-verifies Saint Marys Hospital and Mayo Eugenio Litta Children’s Hospital as Level 1 trauma centers

Saint Marys Hospital and Mayo Eugenio Litta Children’s Hospital recently received re-verification as Level 1 adult and pediatric trauma centers, respectively, by the American College of Surgeons (ACS). The ACS verification recognizes Mayo Clinic’s dedication to providing the highest-quality trauma care for all injured patients. Mayo Eugenio Litta Children’s Hospital is the first children’s hospital in Minnesota to receive verification as an independent level one pediatric trauma center.

24 Feb 2010

Mouse study provides new way to test novel therapies for liver infections

How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver.

24 Feb 2010

Gene expression in prostate cancer cell more complex than ever imagined

Scientists from Sydney's Garvan Institute of Medical Research have published a paper, online today in Nature Cell Biology, describing gene expression in a prostate cancer cell: more sweeping, more targeted and more complex than we could ever have imagined, even five years ago.

24 Feb 2010

Cancer News and Research

Latest Cancer News and Research

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

Researchers to test Radio-embolisation technique in patients with bowel cancer

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Novelos Therapeutics' NOV-002 Phase 3 NSCLC trial fails to meet primary survival endpoint

Researchers team up to monitor and assess potential infectious disease threats to Vancouver

Synovis Life Technologies reports net revenue of $15.2M for first-quarter fiscal 2010

Lack of knowledge and awareness impeding efforts to control HBV and HCV

Frozen/thawed ovarian tissue transplant: Woman has two children from separate pregnancies

Over-produced PKC-iota oncogene linked to poor pancreatic cancer patient survival

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

Phase III trial results of Osiris Therapeutics' Prochymal for GvHD to be presented at BMT Tandem Meeting

Guardian offers six questions to help employees and their families avoid critical illness

ES cells-functions: Condensins promote mitotic progression and maintain interphase chromatin compaction

Idera Pharmaceuticals presents IMO-3100 TLR antagonist mechanism of action data at Keystone conference

Religious belief can reduce depression symptoms

USPSTF-recommended guidelines lead to decline in mammograms and early detection programs for women under 50

Arsenic exposure may increase cancer risk, says study

ACS re-verifies Saint Marys Hospital and Mayo Eugenio Litta Children’s Hospital as Level 1 trauma centers

Mouse study provides new way to test novel therapies for liver infections

Gene expression in prostate cancer cell more complex than ever imagined

Cancer Research - Second Edition eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Newsletters you may be interested in